You are viewing: China Custom Antibody Market analysis
Part of: Custom Antibody Market (Global)

The China Custom Antibody Market was valued at $26.9 Million in 2024 and projected to reach to $45.2 Million by 2029, representing a compound annual growth rate of 10.9%. China's custom antibody market is poised for sustained growth through 2029, supported by accelerating biopharmaceutical R&D activities and increased government funding for life sciences innovation.

China Custom Antibody Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Custom Antibody Market Trends and Insights

  • This growth trajectory reflects China's strengthening position in biopharmaceutical research and development, driven by increased investment in therapeutic antibody development and rising demand from domestic pharmaceutical companies.
  • China's expanding biotech ecosystem and government support for life sciences innovation are accelerating adoption of custom antibody solutions across research institutions and commercial entities. The 10.9% compound annual growth rate (CAGR) in China significantly outpaces global trends, underscoring the country's strategic importance in the custom antibody sector.
  • China's growing capabilities in monoclonal antibody manufacturing and immunotherapy research are attracting both domestic and international collaborations.
  • By 2029, China is expected to consolidate its role as a critical hub for custom antibody development, supported by cost-competitive manufacturing and expanding clinical trial infrastructure..

Key Market Statistics

  • CAGR (2024-2029) 10.9% CAGR
  • Market Size, 2024 ~USD 26.9 Million
  • Forecast, 2029 ~USD 45.2 Million
  • Country China

China Custom Antibody Market Overview

Rapid Market Expansion :

China's custom antibody market is growing at 10.9% CAGR, outpacing the global rate of 9.2%, driven by increased R&D investments and domestic pharmaceutical innovation.

Strong Valuation Growth :

Market size is projected to expand from USD 26.9 million in 2024 to USD 45.2 million by 2029, representing a 68% increase over five years.

Biopharmaceutical Sector Momentum :

China's strengthening position in therapeutic antibody development is fueled by government support, rising biotech investments, and growing demand from domestic pharmaceutical companies.

Strategic Research Hub Development :

Expansion of research capabilities and manufacturing infrastructure positions China as a key player in custom antibody production for both domestic and international markets.

China Custom Antibody Market Dynamics

  • The country's expanding ecosystem of biotech companies and contract research organizations is driving demand for specialized antibody solutions.
  • Domestic pharmaceutical firms are increasingly investing in therapeutic antibody development, creating significant opportunities for custom antibody manufacturers and service providers. The market outlook remains positive as China strengthens its position in the global biopharmaceutical supply chain.
  • Rising healthcare expenditures, coupled with initiatives to develop innovative treatments, will continue to propel market expansion.
  • Strategic partnerships between Chinese biotech firms and international pharmaceutical companies are expected to further accelerate adoption of custom antibody technologies and services..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • China's custom antibody market is valued at USD 26.9 million in 2024 and will grow to USD 45.2 million by 2029, representing a 10.9% CAGR.
    • China's growth rate significantly exceeds global averages, positioning the country as a high-growth market within the Asia Pacific region.
    • Government support for biotechnology and rising R&D investments are driving custom antibody adoption across China's pharmaceutical and research sectors.
    • China's cost-competitive manufacturing and expanding clinical infrastructure position it as an attractive hub for custom antibody development and production.

    Custom Antibody Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment ONCOLOGY (Indication)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.2% from 2024 to 2029
    Largest Segment RESEARCH (Application)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.9 (2029)
    Segments Covered Service, Type, Source, Application, Indication, End User

    China Custom Antibody Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Service

    • Antibody Development
    • Antibody Fragmentation & Labeling
    • Antibody Fragmentation & Labelling
    • Antibody Production & Purification

    By Type

    • Antibody Characterization
    • Antigen Preparation
    • Immunization & Hybridoma Production
    • Monoclonal Antibodies
    • Other Antibodies
    • Other Custom Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies

    By Source

    • Mice
    • Other Sources
    • Rabbits

    By Application

    • Research
    • Therapeutic

    By Indication

    • Cardiovascular Diseases
    • Immunology
    • Infectious Diseases
    • Neurobiology
    • Oncology
    • Other Indications

    By End User

    • Academic & Research Institutes
    • Contract Research Organizations
    • Cros
    • Pharmaceutical & Biotechnology Companies

    CHINA: CUSTOM ANTIBODY MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES13.614.215.416.918.620.622.925.510.6
    CONTRACT RESEARCH ORGANIZATIONS333.23.53.84.14.54.98.7
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES25.22729.432.435.839.844.349.611
    TOTAL41.844.148.152.758.264.571.78010.7

    Target Audience

    • Biopharmaceutical Companies : Chinese and international pharma firms need market intelligence to assess custom antibody sourcing opportunities, competitive positioning, and R&D investment priorities within China's expanding biotech ecosystem.
    • Contract Research Organizations (CROs) : CROs operating in or targeting China require detailed market data to evaluate service demand, pricing strategies, capacity planning, and growth opportunities in therapeutic antibody development.
    • Antibody Manufacturing Providers : Custom antibody manufacturers need China-specific insights to identify market entry points, understand local competition, assess customer demand, and develop localized business strategies.
    • Investment & Venture Capital Firms : Investors evaluating biotech opportunities in China require comprehensive market analysis to identify promising startups, assess market growth potential, and make informed funding decisions.
    • Healthcare & Life Sciences Consultants : Consultants advising clients on China market expansion need detailed market segmentation, growth forecasts, and competitive landscape data to develop effective market entry and growth strategies.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation metrics for China's custom antibody market with verified 2024 baseline (USD 26.9M) and 2029 forecast (USD 45.2M), enabling accurate business planning and investment decisions.
    • Competitive Intelligence : Understand China-specific market dynamics, local player positioning, and growth drivers that differentiate this market from global trends, supporting strategic market entry and expansion strategies.
    • Investment & Funding Insights : Identify high-growth opportunities within China's biopharmaceutical sector, including emerging therapeutic antibody segments and contract research demand from domestic pharmaceutical companies.
    • Regulatory & Market Landscape : Gain insights into China's unique regulatory environment, government support initiatives, and infrastructure development that impact custom antibody market accessibility and growth potential.
    • Strategic Partnership Opportunities : Leverage detailed China market analysis to identify collaboration prospects with local biotech firms, research institutions, and pharmaceutical companies driving custom antibody adoption.

    Frequently asked questions

    What is the current size of China's custom antibody market?

    China's custom antibody market was valued at USD 26.9 million in 2024 and is expected to grow to USD 45.2 million by 2029.

    What is the projected growth rate for China's custom antibody market?

    China's custom antibody market is projected to grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2029.

    What factors are driving growth in China's custom antibody market?

    Key drivers include government support for biotechnology, increased R&D investments, rising demand from domestic pharmaceutical companies, and China's expanding capabilities in monoclonal antibody manufacturing and immunotherapy research.

    How does China's custom antibody market growth compare to global trends?

    China's 10.9% CAGR significantly outpaces the global market CAGR of 9.2%, reflecting China's strategic importance and accelerating adoption of custom antibody solutions.

    What role does China play in the global custom antibody market?

    China is emerging as a critical hub for custom antibody development and manufacturing, supported by cost-competitive production, expanding clinical trial infrastructure, and increasing international collaborations.

    RESEARCH METHODOLOGY

    This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information to analyze the global custom antibody market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the custom antibody market. The secondary sources used for this study include Antibody Society, Antibody Therapeutics, Pharmaceutical Research and Manufacturers of America (PhRMA), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), American Medical Association (AMA), Association of Medical Laboratory Immunologists (AMLI), Central Drugs Standard Control Organisation (CDSCO), Center for Drug Evaluation and Research (CDER), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), World Health Organization (WHO), United States Food & Drug Administration (USFDA), Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global custom antibody market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from pharmaceutical & and biotechnology companies, academic & research institutes, and contract research organizations) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Custom Antibody Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the custom antibody market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the custom antibody market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Custom Antibody Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Custom Antibody Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Custom antibody services include the production of antibodies from a wide variety of host species, depending on the desired outcome of the research study. These services range from antigen preparation, immunization, hybridoma production, and antibody characterization to production, purification, and labeling. The report includes the market size and forecast for the services used for custom antibody development, production, purification, and labeling.

    The study provides an in-depth analysis of the custom antibody market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key custom antibody service providers

    Stakeholders

    • Academic & Research Institutes
    • Custom Antibody Service Vendors
    • Contract Research Organizations (CROs)
    • Medical Device Companies
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Private Research Firms

    Report Objectives

    • To define, describe, and forecast the global custom antibody market based on service, type, source, application,  indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global custom antibody market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations in the custom antibody market
    • To benchmark players in the custom antibody market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe custom antibody market, by country
    • Further breakdown of the Rest of Asia Pacific custom antibody market, by country
    • Further breakdown of the Rest of Latin America custom antibody market, by country
    • Further breakdown of the Rest of Middle East custom antibody market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other technologies and other therapeutic area into subsegments
    • Cross-segment analysis

    Get the Full Custom Antibody Market Report

    Full forecast, segment splits, and company analysis for all Custom Antibody Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status